Table 2.

Mouse-specific primers.

Primers	sequence
MAARS forward	TCACTTGTGCCCTGACTCTG
MAARS reverse	TCTCCAGCAACACAATCCAG
MAARS 5′RACE	GATTACGCCAAGCTTGGTAGGCTAAGGCTCAAAGCCTGGAACA
HuR forward	TTCTCGGTTTGGGCGAATCA
HuR reverse	ACTTCACTGTGATGGGCTCG
BCL2 forward	GAACTGGGGGAGGATTGTGG
BCL2 reverse	GCATGCTGGGGCCATATAGT
MCL1 forward	TGCTCCGGAAACTGGACATT
MCL1 reverse	TCCTGCCCCAGTTTGTTACG
Prothymosin A forward	CTCTCGCCAGAGTCCTCGAA
Prothymosin A reverse	GGAGCTGGTATCCACTGCC
Caspase-9 forward	TCCTGGTACATCGAGACCTTG
Caspase-9 reverse	AAGTCCCTTTCGCAGAAACAG
Caspase-8 forward	TGCTTGGACTACATCCCACAC
Caspase-8 reverse	TGCAGTCTAGGAAGTTGACCA
Caspase-3 forward	ATGGAGAACAACAAAACCTCAGT
Caspase-3 reverse	TTGCTCCCATGTATGGTCTTTAC
BAX forward	TGAAGACAGGGGCCTTTTTG
BAX reverse	AATTCGCCGGAGACACTCG
CDKN1B (p27) forward	TCAAACGTGAGAGTGTCTAACG
CDKN1B (p27) reverse	CCGGGCCGAAGAGATTTCTG
p53 forward	GTCACAGCACATGACGGAGG
p53 reverse	TCTTCCAGATGCTCGGGATAC
IL-1B forward	ATGCCACCTTTTGACAGTGATG
IL-1B reverse	AGCTTCTCCACAGCCACAAT
COX-2 forward	TTCAACACACTCTATCACTGGC
COX-2 reverse	AGAAGCGTTTGCGGTACTCAT
TNFa forward	CCCTCACACTCAGATCATCTTCT
TNFa reverse	GCTACGACGTGGGCTACAG
MCP-1 forward	TTAAAAACCTGGATCGGAACCAA
MCP-1 reverse	GCATTAGCTTCAGATTTACGGGT
Mac2 forward	GGAGAGGGAATGATGTTGCCT
Mac2 reverse	TCCTGCTTCGTGTTACACACA
GAPDH forward	AGGTCGGTGTGAACGGATTTG
GAPDH reverse	TGTAGACCATGTAGTTGAGGTCA
U6 forward	CTCGCTTCGGCAGCACA
U6 reverse	AACGCTTCACGAATTTGCGT
AREs synthetic RNA oligonucleotides	UCAUUAUUUAUUACGAUUUAUUUAUUAGCGAUUUAUUUAUUUACG